The biodefense market encompasses the development, production, and deployment of medical and technological solutions aimed at protecting populations against biological threats, including pathogens and bioterrorism. This sector includes vaccines, diagnostics, surveillance systems, and therapeutic measures, all designed to mitigate risks and enhance national security. It is driven by increasing geopolitical tensions, technological advancements, and the necessity for robust public health infrastructure.